Mechanism of acetaminophen inhibition of cyclooxygenase isoforms

被引:126
作者
Ouellet, M [1 ]
Percival, MD [1 ]
机构
[1] Merck Frosst Ctr Therapeut Res, Dept Biochem & Mol Biol, Kirkland, PQ H9R 4P8, Canada
关键词
acetaminophen; cyclooxygenase; glutathione; peroxidase; reducing agent; hydroperoxide; NSAID; analgesic; antipyretic; antiinflammatory;
D O I
10.1006/abbi.2000.2232
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Acetaminophen has similar analgesic and antipyretic properties to nonsteroidal antiinflammatory drugs (NSAIDs), which act via inhibition of cyclooxygenase enzymes. However, unlike NSAIDs, acetaminophen is at best weakly antiinflammatory, The mechanism by which acetaminophen exerts its therapeutic action has yet to be fully determined, as under most circumstances, acetaminophen is a very weak cyclooxygenase inhibitor. The potency of acetaminophen against both purified ovine cyclooxygenase-1 (oCOX-1) and human cyclooxygenase-2 (hCOX-2) was increased approximately 30-fold by the presence of glutathione peroxidase and glutathione to give IC50 values of 33 muM and 980 muM, respectively. Acetaminophen was found to be a good reducing agent of both oCOX-1 and hCOX-2, The results are consistent with a mechanism of inhibition of acetaminophen in which it acts to reduce the active oxidized form of COX to the resting form. Inhibition would therefore be more effective under conditions of low peroxide concentration, consistent with the known tissue selectivity of acetaminophen, (C) 2001 Academic Press.
引用
收藏
页码:273 / 280
页数:8
相关论文
共 39 条
[1]  
Bambai B, 2000, J BIOL CHEM, V275, P27608
[2]   3,5-disubstituted analogues of paracetamol. Synthesis, analgesic activity and cytotoxicity [J].
Bessems, JGM ;
Gaisser, HD ;
Koppele, JMT ;
VanBennekom, WP ;
Commandeur, JNM ;
Vermeulen, NPE .
CHEMICO-BIOLOGICAL INTERACTIONS, 1995, 98 (03) :237-250
[3]   Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2 [J].
Brooks, P ;
Emery, P ;
Evans, JF ;
Fenner, H ;
Hawkey, CJ ;
Patrono, C ;
Smolen, J ;
Breeveld, F ;
Day, R ;
Dougados, M ;
Ehrich, EW ;
Gijon-Baños, J ;
Kvien, TK ;
Van Rijswijk, MH ;
Warner, T ;
Zeidler, H .
RHEUMATOLOGY, 1999, 38 (08) :779-788
[4]  
Brune K, 1994, Drugs, V47 Suppl 5, P21, DOI 10.2165/00003495-199400475-00005
[5]  
Chan CC, 1999, J PHARMACOL EXP THER, V290, P551
[6]   EFFECT OF SUBSTRATE CONCENTRATION ON INHIBITION OF PROSTAGLANDIN SYNTHETASE OF BULL SEMINAL-VESICLES BY ANTI-INFLAMMATORY DRUGS AND FENAMIC ACID ANALOGS [J].
CUSHMAN, DW ;
CHEUNG, HS .
BIOCHIMICA ET BIOPHYSICA ACTA, 1976, 424 (03) :449-459
[7]   HIGHER OXIDATION-STATES OF PROSTAGLANDIN-H SYNTHASE - RAPID ELECTRONIC SPECTROSCOPY DETECTED 2 SPECTRAL INTERMEDIATES DURING THE PEROXIDASE REACTION WITH PROSTAGLANDIN-G2 [J].
DIETZ, R ;
NASTAINCZYK, W ;
RUF, HH .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1988, 171 (1-2) :321-328
[8]   INHIBITION OF PROSTAGLANDIN SYNTHETASE IN BRAIN EXPLAINS ANTIPYRETIC ACTIVITY OF PARACETAMOL (4-ACETAMIDOPHENOL) [J].
FLOWER, RJ ;
VANE, JR .
NATURE, 1972, 240 (5381) :410-&
[9]   Current concepts of the actions of paracetamol (acetaminophen) and NSAIDS [J].
Graham G.G. ;
Day R.O. ;
Milligan M.K. ;
Ziegler J.B. ;
Kettle A.J. .
InflammoPharmacology, 1999, 7 (3) :255-263
[10]   MODIFICATION OF ANTI-INFLAMMATORY DRUG EFFECTIVENESS BY AMBIENT LIPID PEROXIDES [J].
HANEL, AM ;
LANDS, WEM .
BIOCHEMICAL PHARMACOLOGY, 1982, 31 (20) :3307-3311